Personnel

OncoMed Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer

Published in Cancer Weekly, March 6th, 2007

OncoMed Pharmaceuticals, a company developing novel therapeutics that target cancer stem cells, announced the appointment of Steven E. Benner, M.D., to the position of Senior Vice President and Chief Medical Officer.

In this newly-created role, Dr. Benner will lead OncoMed's clinical development efforts, reporting directly to Paul Hastings, OncoMed's President and Chief Executive Officer. Dr. Benner joins OncoMed from PDL BioPharma (formerly known as Protein Design Labs) where he served as Senior Vice President and Chief Medical Officer.

"We are excited to have Steve join the OncoMed team as we advance novel monoclonal antibodies targeting cancer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry